
### [NCIT:C3465](http://purl.obolibrary.org/obo/NCIT_C3465)
**Label:** Grade 1 Follicular Lymphoma

**Subclasses:** [NCIT:C8071](http://purl.obolibrary.org/obo/NCIT_C8071) (Stage I Grade 1 Follicular Lymphoma), [NCIT:C8129](http://purl.obolibrary.org/obo/NCIT_C8129) (Stage III Grade 1 Follicular Lymphoma), [NCIT:C8116](http://purl.obolibrary.org/obo/NCIT_C8116) (Stage II Grade 1 Follicular Lymphoma), [NCIT:C8155](http://purl.obolibrary.org/obo/NCIT_C8155) (Recurrent Grade 1 Follicular Lymphoma), [NCIT:C8142](http://purl.obolibrary.org/obo/NCIT_C8142) (Stage IV Grade 1 Follicular Lymphoma), [NCIT:C7220](http://purl.obolibrary.org/obo/NCIT_C7220) (Grade 1 Cutaneous Follicular Lymphoma), 

**Class expressions from DL-Learner:**

- Thing 54.80%
- [NCIT:C28077](http://purl.obolibrary.org/obo/NCIT_C28077) (Grade 1) 51.39%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 36.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39740](http://purl.obolibrary.org/obo/NCIT_C39740) (Lung Inflammatory Myofibroblastic Tumor))) 36.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39739](http://purl.obolibrary.org/obo/NCIT_C39739) (Negative Peripheral Blood))) 36.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39725](http://purl.obolibrary.org/obo/NCIT_C39725) (Immunodeficiency))) 36.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39721](http://purl.obolibrary.org/obo/NCIT_C39721) (Abundance of Small Lymphocytes))) 36.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39720](http://purl.obolibrary.org/obo/NCIT_C39720) (Classical Reed-Sternberg Cell))) 36.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3972](http://purl.obolibrary.org/obo/NCIT_C3972) (Prostate Fibroma))) 36.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39719](http://purl.obolibrary.org/obo/NCIT_C39719) (PDGFRalpha Protein Overexpression))) 36.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39718](http://purl.obolibrary.org/obo/NCIT_C39718) (PDGFRA Gene Mutation))) 36.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39717](http://purl.obolibrary.org/obo/NCIT_C39717) (MDM2 Gene Mutation))) 36.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39716](http://purl.obolibrary.org/obo/NCIT_C39716) (EGFR Protein Overexpression))) 36.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39715](http://purl.obolibrary.org/obo/NCIT_C39715) (CD30-Positive Neoplastic Cells Present))) 36.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39712](http://purl.obolibrary.org/obo/NCIT_C39712) (KIT Gene Mutation))) 36.74%


